Drugs / G04CB02
last change Feb 2023 re-read 3 minutes ago

G04CB02

Developed for
amyotrophic lateral sclerosis
Investigated by
Catholic University of Valencia Saint Vicent Martyr

Trials 1

20222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT04654689 Nov 2021 → Nov 2022 amyotrophic lateral sclerosis Catholic University of Valencia Saint Vicent Martyr Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as G04CB02 ClinicalTrials.gov intervention name — accepted as the source's own label NCT04654689 ↗